More engagement is on the lips and on the wish list of every marketer. The common understanding is that “engagement” is an aggregate measure of a variety of interactions, which include clicks, likes, comments, shares, downloads, sign-ups, retweets and re-posts. Engagement is a proxy for conversion in environments where goods and services aren’t directly sold. […]
There is a persistent belief in the wisdom of the crowd. In the public square, this belief plays out in our jury system. Online it plays out daily with the creation and trafficking of user-generated content (UGC). Each day hundreds of millions of photos, videos, social media comments, peer and product reviews, tweets, pins, conversations, […]
The race to develop a COVID-19 vaccine is complicated and challenging. The media is filled with wishful thinking, random prognosticators and a healthy dose of hype. A handful of efforts are entering Phase 3 clinical trials to test different vaccines. As developments occur, consider these six factors in evaluating the news. Developers. Some of the […]
COVID-19 has been an incredible digital accelerator. Now every brand and every company, in the absence of in-person detailing and live congresses, is rushing to exploit digital and social non personal promotion (NPP). Brands are creating multi-stage email campaigns, MoA and KOL videos, social media posts and ads, display and retargeted digital ads, webinars, and […]
While COVID-19 has captured the attention of the world, it hasn’t closed down exploration and development of new drugs and new therapies. In many sectors of the healthcare and biopharma universe, innovative thinking and new clinical approaches by entrepreneurial companies are competing to bring exciting and effective new products to market. LiveWorld studied several of […]
This article was previously published in PM360 on April 15, 2020. This is part 3 of 3 in the article series: Thinking More Digitally in the Age of Coronavirus “As hospitals struggle with a surge of coronavirus infection patients, a second crisis is brewing in physicians’ offices… steep drop-offs in visits as patients stay away, fearful […]
This is Part 2 of 3 in a series: Thinking More Digitally in the Age of Coronavirus The tried and true formula of sustained face to face relationships between HCPs and pharma reps is becoming a thing of the past: The steady decline of rep access coupled with the Covid-19 pandemic, focus our thinking on the […]
